Open Access
Table 3
Distribution of NM studies exposure level collected, analyzed, and reported by the participant of the practical part.
| Study Type | Number | Study Type | Number |
|---|---|---|---|
| 99m Tc-MDP (Oncologic bone scan) | 20 | 99m Tc- DMSA Renal | 2 |
| 99m Tc-MDP SPECT/CT | 8 | 99m Tc- DMSA Renal pediatric patients | 2 |
| 99m Tc-MDP Oncologic Pediatric patients | 8 | 99mTc-MIBI Cardiac Perfussion studies | 5 |
| 18F-FDG (PET/CT) | 17 | 99mTc-MIBI Parathyroid | 2 |
| 68Ga-DOTA (PET/CT) | 1 | 99m Tc- DTPA Renal | 4 |
| 18F-PSMA (PET/CT) | 1 | 99m Tc- DTPA Renal Pediatric patients | 2 |
| Tiroides (99m Tc- Pertecnetate) | 1 | 99mTc-Nanocolloid | 1 |
| 201Tl- cloruro Cardiac Perfussion studies | 1 | 131 I-Iodine (Thyroid cancer survey) | 1 |
| 99m Tc- MAG-3 Renal | 1 | 131 I-Iodine (Thyroid uptake) | 1 |
| Total | 78 |
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.